Avelas Biosciences to Present at Needham & Company 16th Annual Healthcare Conference

Thursday, March 30, 2017 Drug News
Email Print This Page Comment
Font : A-A+

SAN DIEGO, March 29, 2017 /PRNewswire/ -- Avelas Biosciences, Inc., a clinical stage oncology-focused company dedicated to

improving cancer patient care from diagnosis through treatment, today announced that Carmine N. Stengone, president and chief executive officer, will present an overview of the company at the Needham & Company 16th
Annual Healthcare Conference on Wednesday, April 5, 2017, at 11:20 a.m. EDT (8:20 a.m. PDT) at the Westin Grand Central Hotel in New York City.

About Avelas Biosciences

Avelas Biosciences is a San Diego-based biotechnology company focused on developing technologies that advance a new standard-of-care for cancer surgery and therapeutic intervention. The company's lead candidate, AVB-620, has completed a Phase 1b clinical trial assessing safety, pharmacokinetics and fluorescence properties using tissue image analysis. The initiation of a Phase 2 clinical trial for AVB-620 in breast cancer is expected in the first half of 2017. In addition, the company is advancing a therapeutic program, which utilizes the same technology platform. Avelas was founded by Avalon Ventures on technology from Roger Y. Tsien, Ph.D., co-winner of the 2008 Nobel Prize in chemistry. For additional information, please visit www.avelasbio.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/avelas-biosciences-to-present-at-needham--company-16th-annual-healthcare-conference-300431286.html

SOURCE Avelas Biosciences, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook